- Home
- KRYS vs AHR Comparison
KRYS vs AHR Comparison
Compare KRYS & AHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRYS
- AHR
- Stock Information
- Founded
- KRYS 2015
- AHR 2013
- Country
- KRYS United States
- AHR United States
- Employees
- KRYS N/A
- AHR N/A
- Industry
- KRYS Biotechnology: Biological Products (No Diagnostic Substances)
- AHR
- Sector
- KRYS Health Care
- AHR
- Exchange
- KRYS Nasdaq
- AHR NYSE
- Market Cap
- KRYS 4.6B
- AHR 4.2B
- IPO Year
- KRYS 2017
- AHR 2024
- Fundamental
- Price
- KRYS $187.96
- AHR $27.32
- Analyst Decision
- KRYS Strong Buy
- AHR Buy
- Analyst Count
- KRYS 7
- AHR 8
- Target Price
- KRYS $210.00
- AHR $26.13
- AVG Volume (30 Days)
- KRYS 245.3K
- AHR 1.3M
- Earning Date
- KRYS 02-19-2025
- AHR 02-27-2025
- Dividend Yield
- KRYS N/A
- AHR 3.66%
- EPS Growth
- KRYS 669.23
- AHR N/A
- EPS
- KRYS 3.00
- AHR N/A
- Revenue
- KRYS $290,515,000.00
- AHR $2,005,322,000.00
- Revenue This Year
- KRYS $483.09
- AHR N/A
- Revenue Next Year
- KRYS $57.70
- AHR $9.49
- P/E Ratio
- KRYS $62.62
- AHR N/A
- Revenue Growth
- KRYS 473.02
- AHR 9.88
- 52 Week Low
- KRYS $109.57
- AHR $12.81
- 52 Week High
- KRYS $219.34
- AHR $29.99
- Technical
- Relative Strength Index (RSI)
- KRYS 73.39
- AHR 41.94
- Support Level
- KRYS $148.00
- AHR $26.61
- Resistance Level
- KRYS $190.00
- AHR $28.57
- Average True Range (ATR)
- KRYS 7.31
- AHR 0.89
- MACD
- KRYS 3.66
- AHR -0.15
- Stochastic Oscillator
- KRYS 93.87
- AHR 22.30
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
About AHR AMERICAN HEALTHCARE REIT INC
American Healthcare REIT Inc is a healthcare-focused real estate investment trust. It owns a diversified portfolio of clinical healthcare real estate properties, focusing primarily on medical office buildings, skilled nursing facilities, senior housing, hospitals, and other healthcare-related facilities. They have four reportable business segments: integrated senior health campuses, outpatient medical, triple-net leased properties and SHOP. It generates majority of revenue through Integrated Senior Health Campuses segment.